Penta Biotech Private Limited - Company Profile

It is a chemicals private limited company based in New Delhi, Delhi, India, established in 2005.
2005 New Delhi, Delhi, India Under Process Of Striking Off
Last Updated:
Access Report
About Penta Biotech Private Limited

Penta Biotech Private Limited, a under process of striking off private limited company, was established on 28 February 2005 in New Delhi, Delhi, India. Engaging in chemical products within the chemicals sector, it holds CIN: U24232DL2005PTC133424. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.16 M.

Its leadership includes Deepak Mehendiratta (Director), Arun Kumar Vasistha (Director). Its latest AGM occurred on 23 September 2015, with the balance sheet filed on 31 March 2015. It is based at B-15 Kalkaji Extn, New Delhi, Delhi, 110019.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232DL2005PTC133424

  • Registration Number

    133424

  • Incorporation Date

    28 February 2005

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.16 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Under Process Of Striking Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.16 M
  • Company Age 21 Year, 2 Months
  • Last Filing with ROC 31 Mar 2015
Company report

Penta Biotech Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Penta Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Penta Biotech Private Limited?
Current Directors
Name Designation Appointment Date Status
Deepak Mehendiratta Director 28 Feb 2005 Current
Arun Kumar Vasistha Director 28 Feb 2005 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Penta Biotech.

Enhance accessibility to Penta Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Penta Biotech revenue growth over time
Penta Biotech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Penta Biotech?

Unlock access to Penta Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Penta Biotech?

Unlock and access historical data on people associated with Penta Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Penta Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Penta Biotech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Penta Biotech
Recent Activity within the Organization
  • Annual General Meeting

    Penta Biotech Private Limited last Annual general meeting of members was held on 23 Sep 2015 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Penta Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    The activity Deepak Mehendiratta was appointed as a Director was appointed as a Director on 28 Feb 2005 & has been associated with this company since 21 years 2 months . was completed.

  • Director Appointment

    The activity Arun Kumar Vasistha was appointed as a Director was appointed as a Director on 28 Feb 2005 & has been associated with this company since 21 years 2 months . was completed.

  • Company Incorporation

    The activity Penta Biotech Private Limited was registered on 28 Feb 2005 with Roc Delhi & aged 21 years 2 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Penta Biotech Private Limited?

The CIN of Penta Biotech Private Limited is U24232DL2005PTC133424.

Where is Penta Biotech Private Limited headquartered?

Penta Biotech Private Limited is headquartered at B-15 Kalkaji Extn, New Delhi, Delhi, 110019.

When was Penta Biotech Private Limited incorporated?

Penta Biotech Private Limited was incorporated on 28 February 2005.

Who are the current directors of Penta Biotech Private Limited?

The current directors of Penta Biotech Private Limited are

What is the primary industry of Penta Biotech Private Limited?

The primary industry of Penta Biotech Private Limited is Chemicals.

Is Penta Biotech Private Limited a listed company?

Penta Biotech Private Limited is unlisted.

What is the capital structure of Penta Biotech Private Limited?

The authorized capital of Penta Biotech Private Limited is ₹0.50 M, and the paid-up capital is ₹0.16 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available